Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents

P-glycoprotein (P-gp) inhibition has been studied to overcome multidrug resistance in cancer chemotherapy but failed in clinical trials due to low/toxic effects. Recently, a dual modulation of transporters and natural derivatives have been examined to surmount this limitation. We examined breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jaeok, Kang, Jiyeon, Kwon, Na-Yun, Sivaraman, Aneesh, Naik, Ravi, Jin, So-Young, Oh, A. Reum, Shin, Jae-Ho, Na, Younghwa, Lee, Kyeong, Lee, Hwa-Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071537/
https://www.ncbi.nlm.nih.gov/pubmed/33921129
http://dx.doi.org/10.3390/pharmaceutics13040559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071537/
https://www.ncbi.nlm.nih.gov/pubmed/33921129
http://dx.doi.org/10.3390/pharmaceutics13040559

Ejemplares similares